{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-reconciling-paper-and-electronic-records”
},
“headline”: “SOP for Reconciling Paper and Electronic Records”,
“description”: “This SOP establishes procedures for reconciling paper and electronic records in clinical trials, ensuring consistency, completeness, and compliance with FDA, EMA, CDSCO, WHO, GDPR, HIPAA, and ICH GCP requirements. It includes hybrid TMF/ISF management, duplicate verification, version control, and inspection readiness.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Reconciling Paper and Electronic Records

Purpose

The purpose of this SOP is to define standardized procedures for reconciling paper and electronic records in clinical trials, ensuring consistency, accuracy, and compliance. Hybrid records (paper + electronic) must be harmonized to maintain data integrity, subject safety, and regulatory inspection readiness.

Scope

This SOP applies to sponsors, investigators, CROs, QA, archivists, and data management personnel handling Trial Master File (TMF), Investigator Site File (ISF), source documents, and essential clinical trial data maintained in both paper and electronic formats. It covers reconciliation, duplicate management, version control, and archiving.

Responsibilities

• Sponsor: Defines reconciliation requirements and ensures oversight of CRO/vendor compliance.
• Investigators: Maintain ISF reconciliation between paper and electronic copies.
• Archivist: Ensures both paper and eArchives are synchronized.
• QA: Conducts audits to confirm consistency of hybrid records.
• Data Management: Manages electronic record updates and versioning.

Accountability

The Sponsor is accountable for ensuring reconciliation processes are defined and implemented. Investigators are accountable for site-level hybrid records, while QA is accountable for compliance verification.

Procedure

1. Identification of Hybrid Records
1.1 Identify documents existing in both paper and electronic formats.
1.2 Maintain Hybrid Record Register (Annexure-1).

2. Reconciliation of TMF and ISF
2.1 Compare paper and electronic TMF/ISF contents quarterly.
2.2 Ensure versions are aligned and discrepancies documented.
2.3 Record reconciliation in TMF/ISF Reconciliation Log (Annexure-2).

3. Duplicate Verification
3.1 Confirm duplicate records contain identical content and signatures.
3.2 Where discrepancies exist, mark as “Superseded” and retain original.

4. Version Control
4.1 Each document must have version numbers and effective dates.
4.2 Ensure electronic version reflects paper version updates and vice versa.

5. Archiving of Hybrid Records
5.1 Archive paper and electronic records under the same index structure.
5.2 Maintain Archive Reconciliation Log (Annexure-3).

6. Regulatory Compliance
6.1 Ensure reconciliation practices comply with FDA, EMA, CDSCO, WHO, GDPR, and HIPAA requirements.
6.2 Maintain inspection readiness at all times.

7. Deviation Management
7.1 Record all reconciliation failures in Deviation Log (Annexure-4).
7.2 Investigate and implement CAPA.

Abbreviations

• SOP: Standard Operating Procedure
• TMF: Trial Master File
• ISF: Investigator Site File
• QA: Quality Assurance
• CRO: Contract Research Organization
• CAPA: Corrective and Preventive Action
• GDPR: General Data Protection Regulation
• HIPAA: Health Insurance Portability and Accountability Act

Documents

1. Hybrid Record Register (Annexure-1)
2. TMF/ISF Reconciliation Log (Annexure-2)
3. Archive Reconciliation Log (Annexure-3)
4. Deviation Log (Annexure-4)

References

• ICH E6(R2/R3) – Essential Documents in Clinical Trials
• FDA – Guidance on Clinical Trial Records
• EMA – Paper and Electronic Record Requirements
• CDSCO – Record Keeping Regulations
• WHO – Data Integrity and Record Management

Version: 1.0

Approval Section

Annexures

Annexure-1: Hybrid Record Register

Annexure-2: TMF/ISF Reconciliation Log

Annexure-3: Archive Reconciliation Log

Annexure-4: Deviation Log

Revision History

For more SOPs visit: Pharma SOP